Fresenius Medical Care : Quartalsfinanzbericht Q1 2021 Präsentation

Q1 2021 CONFERENCE CALL MAY 6, 2021

Rice Powell - CEO

Helen Giza - CFO

© Copyright

Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy or might not even be anticipated. The Company has based these forward-looking statements on current estimates and assumptions which we believe are reasonable and which are made to the best of our knowledge. Actual results could differ materially from those included in the forward-looking statements due to various risk factors and uncertainties, including changes in business, economic or competitive conditions, changes in reimbursement, regulatory compliance issues, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, cyber security issues and the availability of financing. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. These and other risks and uncertainties are discussed in detail in Fresenius Medical Care AG & Co. KGaA's (FMC AG & Co. KGaA) Annual Report on Form 20-F under the heading "Forward-Looking Statements" and under the headings in that report referred to therein, and in FMC AG & Co. KGaA's other reports filed with the Securities and Exchange Commission (SEC) and the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse).

Forward-looking statements represent estimates and assumptions only as of the date that they were made. The information contained in this presentation is subject to change without notice and the company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable law and regulations.

If not mentioned differently the term net income after minorities refers to the net income attributable to the shareholders of Fresenius Medical Care AG Co. KGaA. The term EMEA refers to the region Europe, Middle East and Africa. Amounts are in Euro if not mentioned otherwise.

© Copyright

1

2

AGENDA

3

BUSINESS UPDATE

FINANCIALS & OUTLOOK

Q&A

Q1 2021 | SOLID RESULTS DESPITE EFFECTS FROM COVID-19

>

>

>

Organic volume growth impacted by COVID-19, as expected

Q1 results adversely affected by exchange rates

Business development supported by improved payor mix driven by Medicare Advantage

• Earnings development supported by phasing and expected lower SG&A expense, anticipated to reverse throughout the year
• Vaccination accelerated to around 51 percent of patients receiving at least the first dose

>

>

Progress on sustainability initiatives reflected in enhanced reporting

Financial targets for FY 2021 confirmed

© │ Conference Call │ Q1 2021

05/06/2021

Page 4

Q1 2021 | QUALITY ON A CONSISTENTLY HIGH LEVEL

+3% Clinics		(1%) Patients
4,110		344,476

	(1%) Treatments		Quality remains
		on a consistently
	13,004,009
		high level

As of March 31, 2021

© │ Conference Call │ Q1 2021

05/06/2021

Page 5